CMKLR1 and glioblastoma: Chemerin, which is primarily expressed in TAMs and partially expressed in GBM cells, promoted the mesenchymal characteristics of GBM by inhibiting the ubiquitin-proteasomal degradation of CMKLR1, increasing NF-κB pathway activation in the process.71